Published in Pituitary on October 01, 2014
Progressive visual disturbance and enlarging prolactinoma caused by melanoma metastasis: A case report and literature review. Medicine (Baltimore) (2017) 0.75
The MCART radiation physics core: the quest for radiation dosimetry standardization. Health Phys (2014) 2.23
Neuroendocrine control of food intake. Nutr Metab Cardiovasc Dis (2007) 2.21
The dexamethasone-suppressed corticotropin-releasing hormone stimulation test and the desmopressin test to distinguish Cushing's syndrome from pseudo-Cushing's states. Clin Endocrinol (Oxf) (2007) 1.73
Aryl hydrocarbon receptor-interacting protein gene mutations in familial isolated pituitary adenomas: analysis in 73 families. J Clin Endocrinol Metab (2007) 1.53
Surgical treatment of giant pituitary adenomas: strategies and results in a series of 95 consecutive patients. Neurosurgery (2007) 1.52
Gynaecomastia in men with chronic myeloid leukaemia after imatinib. Lancet (2003) 1.47
Molecular and cytogenetic subgroups of oropharyngeal squamous cell carcinoma. Clin Cancer Res (2006) 1.37
Primary treatment of acromegaly with octreotide LAR: a long-term (up to nine years) prospective study of its efficacy in the control of disease activity and tumor shrinkage. J Clin Endocrinol Metab (2006) 1.35
Role of epigenetics in human aging and longevity: genome-wide DNA methylation profile in centenarians and centenarians' offspring. Age (Dordr) (2012) 1.33
Acromegaly. Pituitary (2006) 1.26
Treatment relevant target immunophenotyping of 139 salivary gland carcinomas (SGCs). Oral Oncol (2009) 1.19
Results of transsphenoidal surgery in a large series of patients with pituitary adenoma. Neurosurgery (2005) 1.16
Subcellular localization of activated leukocyte cell adhesion molecule is a molecular predictor of survival in ovarian carcinoma patients. Clin Cancer Res (2008) 1.16
Four-year treatment with octreotide-long-acting repeatable in 110 acromegalic patients: predictive value of short-term results? J Clin Endocrinol Metab (2003) 1.15
Partial surgical removal of growth hormone-secreting pituitary tumors enhances the response to somatostatin analogs in acromegaly. J Clin Endocrinol Metab (2005) 1.13
Isolated corticotrophin deficiency. Pituitary (2006) 1.11
Cortisol and ACTH response to oral dexamethasone in obesity and effects of sex, body fat distribution, and dexamethasone concentrations: a dose-response study. J Clin Endocrinol Metab (2002) 1.11
Neurosurgical treatment of craniopharyngioma in adults and children: early and long-term results in a large case series. J Neurosurg (2011) 1.10
Caution during use of desmopressin in IPSS. J Neurointerv Surg (2012) 1.07
Hypopituitarism. Pituitary (2006) 1.06
PDGFRA, PDGFRB, EGFR, and downstream signaling activation in malignant peripheral nerve sheath tumor. Neuro Oncol (2009) 1.04
Gender-related differences in the presentation and course of Cushing's disease. J Clin Endocrinol Metab (2003) 1.03
The delayed pulmonary syndrome following acute high-dose irradiation: a rhesus macaque model. Health Phys (2014) 1.02
Low circulating IGF-I bioactivity is associated with human longevity: findings in centenarians' offspring. Aging (Albany NY) (2012) 1.01
Non-functioning pituitary adenoma database: a useful resource to improve the clinical management of pituitary tumors. Eur J Endocrinol (2006) 1.01
Specificity of first-line tests for the diagnosis of Cushing's syndrome: assessment in a large series. J Clin Endocrinol Metab (2007) 0.99
The PPAR-γ agonist troglitazone antagonizes survival pathways induced by STAT-3 in recombinant interferon-β treated pancreatic cancer cells. Biotechnol Adv (2011) 0.98
Molecular characterization of synovial sarcoma in children and adolescents: evidence of akt activation. Transl Oncol (2008) 0.98
Midnight salivary cortisol versus urinary free and midnight serum cortisol as screening tests for Cushing's syndrome. J Clin Endocrinol Metab (2003) 0.98
Vitamin D status in women with uterine leiomyomas. J Clin Endocrinol Metab (2013) 0.97
Delayed remission after transsphenoidal surgery in patients with Cushing's disease. J Clin Endocrinol Metab (2010) 0.95
NMDA receptor composition differs among anatomically diverse malformations of cortical development. J Neuropathol Exp Neurol (2006) 0.94
Nutritional status in the neuroendocrine control of growth hormone secretion: the model of anorexia nervosa. Front Neuroendocrinol (2003) 0.93
Metallothionein 1G acts as an oncosupressor in papillary thyroid carcinoma. Lab Invest (2008) 0.93
The expression of VGF is reduced in leukocytes of depressed patients and it is restored by effective antidepressant treatment. Neuropsychopharmacology (2010) 0.93
Growth hormone deficiency (GHD) in adult thalassaemic patients. Clin Endocrinol (Oxf) (2007) 0.92
Potential role for retinoic acid in patients with Cushing's disease. J Clin Endocrinol Metab (2012) 0.92
Effects of treatment with somatostatin analogues on QT interval duration in acromegalic patients. Clin Endocrinol (Oxf) (2006) 0.90
Bone morphogenetic protein-4 inhibits corticotroph tumor cells: involvement in the retinoic acid inhibitory action. Endocrinology (2005) 0.89
Fresh blastocyst transfer as a clinical approach to overcome the detrimental effect of progesterone elevation at hCG triggering: a strategy in the context of the Italian law. Eur J Obstet Gynecol Reprod Biol (2013) 0.89
Clinical relevance of cardiac structure and function abnormalities in patients with Cushing's syndrome before and after cure. Clin Endocrinol (Oxf) (2012) 0.89
Elastosonographic evaluation of thyroid nodules in acromegaly. Eur J Endocrinol (2009) 0.89
Effects of lanreotide Autogel on growth hormone, insulinlike growth factor 1, and tumor size in acromegaly: a 1-year prospective multicenter study. Endocr Pract (2008) 0.89
High-mobility group A2 gene expression is frequently induced in non-functioning pituitary adenomas (NFPAs), even in the absence of chromosome 12 polysomy. Endocr Relat Cancer (2005) 0.89
Vitamin D deficiency and infertility: insights from in vitro fertilization cycles. J Clin Endocrinol Metab (2014) 0.89
ACTH-secreting pheochromocytoma with false-negative ACTH immunohistochemistry. Endocr Pathol (2012) 0.88
Surgical strategies and modern therapeutic options in the treatment of craniopharyngiomas. Crit Rev Oncol Hematol (2013) 0.88
Lymphocytic hypophysitis: differential diagnosis and effects of high-dose pulse steroids, followed by azathioprine, on the pituitary mass and endocrine abnormalities--report of a case and literature review. ScientificWorldJournal (2010) 0.88
The High Mobility Group A2 gene is amplified and overexpressed in human prolactinomas. Cancer Res (2002) 0.87
Assessment of ACTH assay variability: a multicenter study. Eur J Endocrinol (2011) 0.87
Localization of vascular endothelial growth factor (VEGF) receptors in normal and adenomatous pituitaries: detection of a non-endothelial function of VEGF in pituitary tumours. J Endocrinol (2006) 0.87
Effect of protracted treatment with rosiglitazone, a PPARgamma agonist, in patients with Cushing's disease. Clin Endocrinol (Oxf) (2006) 0.86
MHC2TA single nucleotide polymorphism and genetic risk for autoimmune adrenal insufficiency. J Clin Endocrinol Metab (2006) 0.86
Somatostatin analogues stimulate p27 expression and inhibit the MAP kinase pathway in pituitary tumours. Eur J Endocrinol (2006) 0.85
Solitary clival plasmocytomas: Misleading clinical and radiological features of a rare pathology with a specific biological behaviour. Acta Neurochir (Wien) (2013) 0.85
Von Willebrand factor and fibrinolytic parameters during the desmopressin test in patients with Cushing's disease. Br J Clin Pharmacol (2011) 0.85
Expression and function of sonic hedgehog pathway components in pituitary adenomas: evidence for a direct role in hormone secretion and cell proliferation. J Clin Endocrinol Metab (2005) 0.85
Skull base tumor model. J Neurosurg (2010) 0.85
Metabolic, cardiovascular, and cerebrovascular outcomes in growth hormone-deficient subjects with previous cushing's disease or non-functioning pituitary adenoma. J Clin Endocrinol Metab (2009) 0.85
Cabergoline addition to depot somatostatin analogues in resistant acromegalic patients: efficacy and lack of predictive value of prolactin status. Clin Endocrinol (Oxf) (2004) 0.84
Cyclin D1 expression analysis in familial breast cancers may discriminate BRCAX from BRCA2-linked cases. Mod Pathol (2008) 0.84
Meningioma presenting with Cushing's syndrome: an unusual clinical presentation. Ann Neurol (2003) 0.84
d3-Growth hormone receptor polymorphism in acromegaly: effects on metabolic phenotype. Clin Endocrinol (Oxf) (2010) 0.84
Time course of hypothalamic-pituitary deficiency in adults receiving cranial radiotherapy for primary extrasellar brain tumors. Radiother Oncol (2011) 0.83
Vitamin D and assisted reproduction technologies: current concepts. Reprod Biol Endocrinol (2014) 0.83
High prevalence of prolonged QT interval in obese hypogonadal males. Obesity (Silver Spring) (2011) 0.83
Drugs and HPA axis. Pituitary (2008) 0.83
The somatostatin analogue octreotide confers sensitivity to rapamycin treatment on pituitary tumor cells. Cancer Res (2010) 0.82
The diagnosis of GH deficiency in obese patients: a reappraisal with GHRH plus arginine testing after pharmacological blockade of lipolysis. Eur J Endocrinol (2010) 0.82
Is autophagy rather than apoptosis the regression driver in imatinib-treated gastrointestinal stromal tumors? Transl Oncol (2008) 0.82
Cushing's disease. Pituitary (2006) 0.81
The pituitary-adrenal axis in adult thalassaemic patients. Eur J Endocrinol (2009) 0.81
[Is there any correlation between psychiatric disease and the teaching profession?]. Med Lav (2004) 0.81
Cushing's disease due to double pituitary ACTH-secreting adenomas: the first case report. Endocr J (2010) 0.81
Effects of growth hormone treatment on arginine to asymmetric dimethylarginine ratio and endothelial function in patients with growth hormone deficiency. Metabolism (2008) 0.81
Thyrotropin-secreting pituitary adenomas: outcome of pituitary surgery and irradiation. J Clin Endocrinol Metab (2014) 0.80
Pose estimation of known objects during transmission tomographic image reconstruction. IEEE Trans Med Imaging (2006) 0.80
Bone demineralization in adult thalassaemic patients: contribution of GH and IGF-I at different skeletal sites. Clin Endocrinol (Oxf) (2008) 0.80
Immunomodulatory effects of VEGF: Clinical implications of VEGF-targeted therapy in human cancer. Cancer Biol Ther (2010) 0.80
Increased insulin-stimulated endothelin-1 release is a distinct vascular phenotype distinguishing Cushing's disease from metabolic syndrome. Clin Endocrinol (Oxf) (2007) 0.80